Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients-Reference-Cited by-同舟云学术

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients

Published:2011-11-04 Issue:1 Volume:33 Page:95-99
ISSN:1059-7794
Container-title:Human Mutation
language:en
Short-container-title:Hum. Mutat.

Author:

Thompson Ella R.,Boyle Samantha E.,Johnson Julie,Ryland Georgina L.,Sawyer Sarah,Choong David Y.H.,kConFab ,Chenevix-Trench Georgia,Trainer Alison H.,Lindeman Geoffrey J.,Mitchell Gillian,James Paul A.,Campbell Ian G.

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Reference19 articles.

1. RAD51C germline mutations in breast and ovarian cancer patients;Akbari;Breast Cancer Res,2010

2. Transforming growth factor beta receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer;Baxter;Cancer Epidemiol Biomarkers Prev,2002

3. Mutation and methylation analysis of the chromodomain-helicase-DNA binding 5 gene in ovarian cancer;Gorringe;Neoplasia,2008

4. Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis;Gorringe;Genes Chromosome Canc,2009

5. Biallelic inactivation of BRCA2 in Fanconi anemia;Howlett;Science,2002

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary fallopian tube cancer followed by primary breast cancer in RAD51C mutation carrier treated with niraparib as first line maintenance therapy: a case report;Hereditary Cancer in Clinical Practice;2024-02-15

2. Molecular genetic markers of ovarian cancer tumor cells and their microenvironment, study methods, and clinical value: A review;Journal of Modern Oncology;2023-12-10

3. RAD51C-XRCC3 structure and cancer patient mutations define DNA replication roles;Nature Communications;2023-07-24

4. Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C;Cancer Research;2023-05-30

5. In Silico-Based Structural Evaluation to Categorize the Pathogenicity of Mutations Identified in the RAD Class of Proteins;ACS Omega;2023-03-08